Cargando…

Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study

BACKGROUND: Present study describe the in vitro model of plasma oxidation of patients with different lipid profile, that can be correlated to their invivo plasma oxidizability in order to find the arterial diseases prone patient groups. METHOD: The method applied here to measure the invitro plasma o...

Descripción completa

Detalles Bibliográficos
Autores principales: Imam, Hasan, Chowdhury, Arfia, Mahbub, Nasir Uddin, Hossain, Amir, Karim, Mohammed Faisal Bin, Uddin, Mohammad Burhan, Sarker, Md Moklesur Rahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031925/
https://www.ncbi.nlm.nih.gov/pubmed/24918093
http://dx.doi.org/10.1186/2251-6581-13-54
_version_ 1782317585777295360
author Imam, Hasan
Chowdhury, Arfia
Mahbub, Nasir Uddin
Hossain, Amir
Karim, Mohammed Faisal Bin
Uddin, Mohammad Burhan
Sarker, Md Moklesur Rahman
author_facet Imam, Hasan
Chowdhury, Arfia
Mahbub, Nasir Uddin
Hossain, Amir
Karim, Mohammed Faisal Bin
Uddin, Mohammad Burhan
Sarker, Md Moklesur Rahman
author_sort Imam, Hasan
collection PubMed
description BACKGROUND: Present study describe the in vitro model of plasma oxidation of patients with different lipid profile, that can be correlated to their invivo plasma oxidizability in order to find the arterial diseases prone patient groups. METHOD: The method applied here to measure the invitro plasma oxidizability, accounts a convenient way that can be well suited in any clinical laboratory settings. Un-fractionated plasma was exposed to CuSO4 (5.0 mmol/L), a pro-oxidant, and low frequency ultrasonic wave to induce oxidation, and finally oxidizability was calculated by TBARS and Conjugated Diene methods. RESULT: In our study, plasma LDL greater than 150 mg/dL possess 1.75 times more risk to undergo oxidation (CI, 0.7774 to 3.94; p = 0.071) than the low LDL plasma, percent of oxidation increased from 38.3% to 67.1% for the LDL level upto 150 mg/dL and high. Lag phase, which is considered as the plasma antioxidative protection, was also influenced by the higher LDL concentration. The mean lag time was 65.27 ± 20.02 (p = 0.02 compared to healthy), where as for 94.71 ± 35.11 min for the normolipidemic subject. The plasma oxidizability was also changed drastically for total cholesterol level, oxidative susceptibility shown 35% and 55.02% for 200 mg/dL and high respectively, however it didn’t appear as risk factor. Patient samples were also stratified according to their age, gender, and blood glucose level. Older persons (≥40 years) were 1.096 times (95% CL, 0.5607 to 2.141, p = 0.396) than younger (≤39 years age), males are 1.071 (95% CI, 0.5072- 2.264) times than the females, and diabetic patients are 1.091 (CI, 0.6153 to 1.934, p = 0.391) times in more risk than the non-diabetic counterpart. CONCLUSION: This method addressing its easy applicability in biomedical research. And by this we were able to show that patients with high LDL (≥150 mg/dL) are in alarming condition besides diabetic and elderly (≥40 years age) males are considered to be susceptible and more prone to develop vascular diseases.
format Online
Article
Text
id pubmed-4031925
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40319252014-06-10 Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study Imam, Hasan Chowdhury, Arfia Mahbub, Nasir Uddin Hossain, Amir Karim, Mohammed Faisal Bin Uddin, Mohammad Burhan Sarker, Md Moklesur Rahman J Diabetes Metab Disord Research Article BACKGROUND: Present study describe the in vitro model of plasma oxidation of patients with different lipid profile, that can be correlated to their invivo plasma oxidizability in order to find the arterial diseases prone patient groups. METHOD: The method applied here to measure the invitro plasma oxidizability, accounts a convenient way that can be well suited in any clinical laboratory settings. Un-fractionated plasma was exposed to CuSO4 (5.0 mmol/L), a pro-oxidant, and low frequency ultrasonic wave to induce oxidation, and finally oxidizability was calculated by TBARS and Conjugated Diene methods. RESULT: In our study, plasma LDL greater than 150 mg/dL possess 1.75 times more risk to undergo oxidation (CI, 0.7774 to 3.94; p = 0.071) than the low LDL plasma, percent of oxidation increased from 38.3% to 67.1% for the LDL level upto 150 mg/dL and high. Lag phase, which is considered as the plasma antioxidative protection, was also influenced by the higher LDL concentration. The mean lag time was 65.27 ± 20.02 (p = 0.02 compared to healthy), where as for 94.71 ± 35.11 min for the normolipidemic subject. The plasma oxidizability was also changed drastically for total cholesterol level, oxidative susceptibility shown 35% and 55.02% for 200 mg/dL and high respectively, however it didn’t appear as risk factor. Patient samples were also stratified according to their age, gender, and blood glucose level. Older persons (≥40 years) were 1.096 times (95% CL, 0.5607 to 2.141, p = 0.396) than younger (≤39 years age), males are 1.071 (95% CI, 0.5072- 2.264) times than the females, and diabetic patients are 1.091 (CI, 0.6153 to 1.934, p = 0.391) times in more risk than the non-diabetic counterpart. CONCLUSION: This method addressing its easy applicability in biomedical research. And by this we were able to show that patients with high LDL (≥150 mg/dL) are in alarming condition besides diabetic and elderly (≥40 years age) males are considered to be susceptible and more prone to develop vascular diseases. BioMed Central 2014-05-01 /pmc/articles/PMC4031925/ /pubmed/24918093 http://dx.doi.org/10.1186/2251-6581-13-54 Text en Copyright © 2014 Imam et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Imam, Hasan
Chowdhury, Arfia
Mahbub, Nasir Uddin
Hossain, Amir
Karim, Mohammed Faisal Bin
Uddin, Mohammad Burhan
Sarker, Md Moklesur Rahman
Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study
title Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study
title_full Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study
title_fullStr Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study
title_full_unstemmed Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study
title_short Oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study
title_sort oxidizability assay of unfractionated plasma of patients’ with different plasma profile: a methodological study
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4031925/
https://www.ncbi.nlm.nih.gov/pubmed/24918093
http://dx.doi.org/10.1186/2251-6581-13-54
work_keys_str_mv AT imamhasan oxidizabilityassayofunfractionatedplasmaofpatientswithdifferentplasmaprofileamethodologicalstudy
AT chowdhuryarfia oxidizabilityassayofunfractionatedplasmaofpatientswithdifferentplasmaprofileamethodologicalstudy
AT mahbubnasiruddin oxidizabilityassayofunfractionatedplasmaofpatientswithdifferentplasmaprofileamethodologicalstudy
AT hossainamir oxidizabilityassayofunfractionatedplasmaofpatientswithdifferentplasmaprofileamethodologicalstudy
AT karimmohammedfaisalbin oxidizabilityassayofunfractionatedplasmaofpatientswithdifferentplasmaprofileamethodologicalstudy
AT uddinmohammadburhan oxidizabilityassayofunfractionatedplasmaofpatientswithdifferentplasmaprofileamethodologicalstudy
AT sarkermdmoklesurrahman oxidizabilityassayofunfractionatedplasmaofpatientswithdifferentplasmaprofileamethodologicalstudy